Question explored with the scientific record
What causes very high blood calcium levels in dogs?
The most common cause of very high blood calcium in dogs is cancer, and the evidence here is clear enough to act on.
Cancer is the driver in about two-thirds of canine hypercalcemia cases [2]. The two tumors most often responsible are lymphoma and anal sac adenocarcinoma [2]. These tumors secrete a substance called parathyroid hormone-related protein (PTHrP) that tricks the body into pulling calcium from bone and holding it in the blood [1, 2]. One case report documented a dog with malignant melanoma and a serum calcium of 16.8 mg/dL (reference range 7.2 to 12.8) alongside a PTHrP level 75 times the upper normal limit [1]. Another report of anal sac adenocarcinoma showed a calcium of 16.3 mg/dL [3].
Vitamin D toxicity is a second, less common cause. Dogs are especially sensitive to the calcemic effects of vitamin D analogs, reaching a mean peak calcium of 18.2 mg/dL in one study at doses that barely moved human calcium [6]. The toxicity threshold for 25(OH)D is around 750 nmol/L [4]. This matters when a dog gets into rodenticide or certain supplements.
A critical diagnostic point: total calcium alone is unreliable. In a study of 1,633 dogs, total calcium misclassified ionized calcium status in 27% of all dogs and 36% of those with chronic kidney failure [5]. Adjusting for albumin or protein made the error worse in kidney failure, not better [5]. Direct ionized calcium measurement is essential before deciding the calcium is truly high or acting on the number.
My call: for a dog with confirmed ionized hypercalcemia, the first search should be for lymphoma or anal sac adenocarcinoma, with PTHrP measurement to confirm the mechanism. Confidence is high that cancer is the most common cause, and moderate that vitamin D toxicity is the next most common, based on the species sensitivity data.
Sources used 6
-
Hypercalcemia and high parathyroid hormone-related protein concentration associated with malignant melanoma in a dog
This study reports a case of a dog with malignant melanoma that exhibited severe hypercalcemia and high levels of parathyroid hormone-related protein (PTHrP), suggesting a link between the tumor and the hypercalcemic condition.
DOI: 10.2460/javma.2002.221.263 -
Paraneoplastic Hypercalcemia
This topical review summarizes the etiology, diagnosis, and management of paraneoplastic hypercalcemia in dogs and cats, highlighting common tumor associations (notably lymphoma and anal sac adenocarcinoma), diagnostic approaches (including PTH and PTHrP assessment), and both su…
DOI: 10.1053/j.tcam.2012.09.003 -
Evaluation of an anal sac adenocarcinoma tumor in a Spitz dog
This is a single-case report detailing the clinical presentation, diagnostic workup (including cytology and histopathology), surgical treatment, and outcome of anal sac adenocarcinoma in a Spitz dog, highlighting hypercalcemia and confirming the diagnosis as the first reported S…
DOI: 10.1016/S2221-1691(13)60027-1 -
Pharmacokinetics of vitamin D toxicity
Hypervitaminosis D toxicity appears linked to extremely high 25(OH)D levels that may overwhelm DBP binding and raise free metabolites, with a practical toxicity threshold near 750 nmol/L of 25(OH)D and limited, inconsistent elevations of the active hormone 1α,25(OH)2D3.
DOI: 10.1093/ajcn/88.2.582s -
Prediction of serum ionized calcium concentration by use of serum total calcium concentration in dogs
Serum total calcium and protein- or albumin-adjusted total calcium are poor predictors of serum ionized calcium status in dogs, especially in chronic renal failure, so direct ionized calcium measurement is recommended.
DOI: 10.2460/ajvr.2005.66.1330 -
Inter-species differences in sensitivity to the calcemic activity of the novel 1,25-dihydroxyvitamin D3 analog BXL746
This study investigates the inter-species differences in sensitivity to the calcemic activity of the novel 1,25-dihydroxyvitamin D3 analog BXL746, revealing that dogs exhibit significantly higher sensitivity to hypercalcemia compared to rats and humans following acute administra…
DOI: 10.1016/j.yrtph.2008.09.002